Now Antidepressant-Induced Chronic Depression Has a Name: Tardive Dysphoria

6
Three recently published papers, along with a report by a Minnesota group on health outcomes in that state, provide new reason to mull over...

Drug Companies ‘Just Say No’ to Psych Drugs

2
The market for psychiatric drugs is, of course,  booming. In 2011, spending on psychiatric medications can expect to top $40 billion. Yet, in spite...

”Broken Brains” and “Beautiful Minds”

0
When I first interviewed Brandon Banks, in the spring of 2008, while researching Anatomy of an Epidemic, he had recently entered Elizabethtown Community College...

Update on the Star*D Report

0
Two months ago, I wrote a post about a New Yorker article that reported that 67% of the depressed patients in the STAR*D trial...

A Schizophrenia Mystery Solved?

1
One of the enduring mysteries in schizophrenia research circles has been the disparity in outcomes between schizophrenia patients in "developing countries" and those in...

Antipsychotics/Schizophrenia

11
The long-term outcomes literature for antipsychotics, which has been compiled over a period of nearly 50 years, consistently tells of drugs that increase the...

Fact Checking the New Yorker, Part Two

0
In his March 1 article in the New Yorker, Louis Menand wrote that the NIMH's STAR*D trial showed that antidepressants produced a 67% recovery...

Fact Checking the New Yorker

0
In the March 1 issue of the New Yorker, Louis Menand surveyed the topsy-turvy world of treatments for depression, writing in part of the...